tetra-n-butylammonium taurinate | 91900-05-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: tetra-n-butylammonium taurinate
• 英文别名: taurine tetrabutylammonium salt；taurine anhydrous tetrabutylammonium salt；2-aminoethanesulfonate;tetrabutylazanium
• CAS: 91900-05-9
• 化学式: C₂H₆NO₃S*C₁₆H₃₆N
• 分子量: 366.609
• InChiKey: YWLHQBNWPCKZSB-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  3.49
• 重原子数：
  24
• 可旋转键数：
  13
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  91.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  tetra-n-butylammonium taurinate 在 盐酸 、 N,N-二异丙基乙胺 、 N,N'-二环己基碳二亚胺 作用下， 以 氯仿 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 1.5h， 生成 9-((2-(4-(4-((4-(dimethylamino)phenyl)(4-(dimethyliminio)cyclohexa-2,5-dien-1-ylidene)methyl)phenoxy)butanamido)ethyl)carbamoyl)-4,7,15,18-tetraoxo-3,8,14,19-tetraazahenicosane-1,21-disulfonate
  参考文献：
  名称：

  Near-instant surface-selective fluorogenic protein quantification using sulfonated triarylmethane dyes and fluorogen activating proteins

  摘要：

  一种双磺酸酯连接物修饰的孔雀绿荧光素改善了其特异性，并允许在活细胞上快速、无需洗涤地标记受体。

  DOI：

  10.1039/c4ob02309a
• 作为产物：
  描述：

  四丁基溴化铵 在 silver(l) oxide 作用下， 以 水 为溶剂， 反应 20.0h， 生成 tetra-n-butylammonium taurinate
  参考文献：
  名称：

  Proximate charge effects. 6. Anion-cation-zwitterion triplets in solution

  摘要：

  DOI：

  10.1021/jo00196a017

文献信息

• N-substituted prodrugs of fluorooxindoles
  申请人：Starrett E. John

  公开号：US20050203089A1

  公开（公告）日：2005-09-15

  The present invention provides novel N-substituted fluorooxindoles having the general Formula I wherein the wavy bond represents the racemate, the (R)-enantiomer or the (S)-enantiomer and m, n, p, q, A, B, D, Q, X, and Z are as defined below, or a nontoxic pharmaceutically acceptable salt or solvate thereof and are useful in the treatment of disorders which are responsive to the opening of potassium channels.

  本发明提供了具有一般式I的新型N-取代氟代草酮，其中波浪键代表消旋体，(R)-对映体或(S)-对映体，m、n、p、q、A、B、D、Q、X和Z如下所定义，或其无毒的药学上可接受的盐或溶剂，用于治疗对钾通道开放有响应的疾病。
• Chemical compounds
  申请人：——

  公开号：US20040067933A1

  公开（公告）日：2004-04-08

  The present invention relates to compounds of the formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described. 1

  本发明涉及式(I)的化合物：（其中变量团如所定义）药用可接受的盐、溶剂化物、这些盐的溶剂化物以及前药及其作为回肠胆酸转运(IBAT)抑制剂用于治疗高脂血症的用途。还描述了它们的制造过程和包含它们的药物组合物。
• Synthesis of Conjugates of Lupane-Type Pentacyclic Triterpenoids with 2-Aminoethane- and N-Methyl-2-Aminoethanesulfonic Acids. Assessment of in vitro Toxicity
  作者：N. G. Komissarova、S. N. Dubovitskii、O. V. Shitikova、E. M. Vyrypaev、L. V. Spirikhin、E. M. Eropkina、T. G. Lobova、M. Yu. Eropkin、M. S. Yunusov

  DOI：10.1007/s10600-017-2153-6

  日期：2017.9

  Conjugates of betulin and betulinic and betulonic acids with 2-aminoethane- and N-methyl-2-aminoethanesulfonic acids were synthesized for the first time and were interesting as potential biologically active compounds. Experiments in vitro in MDCK cell culture using the MTT assay found that betulin and betulinic-acid derivatives with aminoethanesulfonic acid bound to triterpene C-3 or C-28 through an ester linker were less toxic than the native compounds.

  首次合成了与2-氨基乙烷酸及N-甲基-2-氨基乙烷磺酸结合的白桦脂醇和白桦脂酸衍生物，这些化合物因其潜在的生物活性而备受关注。在MDCK细胞培养中进行MTT试验的体外实验表明，通过酯连接体将氨基乙烷磺酸结合在三萜C-3或C-28位置的白桦脂醇和白桦脂酸衍生物，其毒性低于母体化合物。
• New Conjugates of Betulin with 2-Aminoethanesulfonic Acid
  作者：N. G. Komissarova、S. N. Dubovitskii、A. V. Orlov、O. V. Shitikova

  DOI：10.1007/s10600-019-02672-0

  日期：2019.3

  New potentially biologically active conjugates of betulin and its 3β-O-acetate with 2-aminoethanesulfonic acid (taurine) linked through succinic or maleic acid were synthesized.

  新型的具有潜在生物活性的桦木醇及其3β-O-乙酸与2-氨基乙磺酸（牛磺酸）通过琥珀酸或马来酸连接的共轭物已被合成。
• Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
  申请人：G.D. Searle & Co.

  公开号：US20020013476A1

  公开（公告）日：2002-01-31

  Provided are novel benzothiepines, derivatives, and analogs thereof; pharmaceutical compositions containing them; and methods of using these compounds and compositions in medicine, particularly in the prophylaxis and treatment of hyperlipidemic conditions such as those associated with atherosclerosis or hypercholesterolemia, in mammals.

  提供了新型苯并噻吩类化合物及其衍生物和类似物；含有它们的药物组合物；以及在医学中使用这些化合物和组合物的方法，特别是在哺乳动物中预防和治疗高脂血症状，如与动脉粥样硬化或高胆固醇血症相关的情况。